DK0469440T3 - Solid oral dosage forms containing as active ingredient ifosamide - Google Patents

Solid oral dosage forms containing as active ingredient ifosamide

Info

Publication number: DK0469440T3
Authority: DK; Denmark
Prior art keywords: ifosamide; active ingredient; dosage forms; oral dosage; solid oral
Prior art date: 1990-08-03

Application number

DK91112368.5T

Other languages

Danish (da)

Inventor

Dieter Sauerbier

Jorgen Dr Engel

Eckhard Dr Milsmann

Klaus Dr Molge

Otto Dr Isaac

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-03

Filing date

1991-07-24

Publication date

1994-11-14

1991-07-24 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

1994-11-14 Application granted granted Critical

1994-11-14 Publication of DK0469440T3 publication Critical patent/DK0469440T3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK91112368.5T 1990-08-03 1991-07-24 Solid oral dosage forms containing as active ingredient ifosamide DK0469440T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4024683		1990-08-03
SG181694A SG181694G (en)	1990-08-03	1994-12-30	Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number	Publication Date
DK0469440T3 true DK0469440T3 (en)	1994-11-14

Family

ID=25895607

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91112368.5T DK0469440T3 (en)	1990-08-03	1991-07-24	Solid oral dosage forms containing as active ingredient ifosamide

Country Status (33)

Country	Link
US (1)	US5158776A (en)
EP (1)	EP0469440B1 (en)
JP (2)	JP3061898B2 (en)
KR (1)	KR0177170B1 (en)
CN (1)	CN1046851C (en)
AR (1)	AR247484A1 (en)
AT (1)	ATE110261T1 (en)
AU (2)	AU643309B2 (en)
BG (1)	BG60900B1 (en)
CA (1)	CA2048367C (en)
CZ (1)	CZ280475B6 (en)
DE (2)	DE59102620D1 (en)
DK (1)	DK0469440T3 (en)
EG (1)	EG19690A (en)
ES (1)	ES2058999T3 (en)
FI (1)	FI97951C (en)
HK (1)	HK15695A (en)
HR (1)	HRP920575B1 (en)
HU (1)	HU206268B (en)
IE (1)	IE66378B1 (en)
IL (1)	IL99031A (en)
LT (1)	LT3528B (en)
LV (1)	LV10043B (en)
MC (1)	MC2274A1 (en)
MX (1)	MX9100441A (en)
NO (1)	NO178252C (en)
NZ (1)	NZ239222A (en)
PT (1)	PT98532B (en)
RO (1)	RO113611B1 (en)
SG (1)	SG181694G (en)
SI (1)	SI9111342B (en)
SK (2)	SK279740B6 (en)
ZA (1)	ZA916124B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7966694A (en) *	1993-07-21	1996-05-02	University Of Kentucky Research Foundation, The	A multicompartment hard capsule with control release properties
ITFI970184A1 (en) *	1997-07-30	1999-01-30	Menarini Farma Ind	PHARMACEUTICAL COMPOSITIONS CONTAINING VITAMIN D AND CALCIUM, THEIR PREPARATION AND THERAPEUTIC USE
DE19733305A1 (en) *	1997-08-01	1999-02-04	Asta Medica Ag	Pharmaceutical composition containing ifosfamide and carnitine
US6103297A (en) *	1998-01-14	2000-08-15	Matsushita Electronics Corporation	Method of manufacturing cathode-ray tube
DE19826517B4 (en) *	1998-06-15	2006-03-23	Baxter Healthcare S.A.	Process for the preparation of film-coated tablets with cyclophosphamide as active ingredient and cyclophosphamide film-coated tablet produced therefrom
US20040253307A1 (en) *	2003-02-04	2004-12-16	Brian Hague	Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (en) *	2005-02-25	2006-09-07	Baxter International Inc., Deerfield	Trofosfamide-containing film-coated tablets and process for their preparation
EP3091974B1 (en)	2014-01-06	2020-04-01	Shield TX (UK) Limited	Dosage regimen of ferric trimaltol
GB201418710D0 (en)	2014-10-21	2014-12-03	Iron Therapeutics Holdings Ag	Dosage regimen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3987204A (en)	1972-09-15	1976-10-19	Sucrest Corporation	Direct compression vehicle
JPS5646807A (en) *	1979-09-27	1981-04-28	Japan Atom Energy Res Inst	Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (en) *	1981-03-24	1982-10-07	Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld	OXAZAPHOSPHORIN-4-THIO-ALKANESULPHONIC ACIDS AND THEIR NEUTRAL SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
US4618692A (en) *	1981-09-03	1986-10-21	Asta-Werke Aktiengesellschaft	4-carbamoyloxy-oxazaphosphorins
US5019385A (en) *	1984-11-09	1991-05-28	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Novel lymphopine LK 2 and pharmaceutic compositions containing same
DE3722043A1 (en) *	1986-07-11	1988-01-14	Asta Werke Ag Chem Fab	SOLUTIONS OF OXAZAPHOSPHORINES WITH IMPROVED STABILITY AND METHOD FOR THE PRODUCTION THEREOF
DE3804686A1 (en) *	1988-02-15	1989-08-24	Henkel Kgaa	MEDICAMENT WITH A COMBINATION OF CYTOSTATIKA BZW. HORMONTHERAPEUTICS AND PHOSPHONOR DERIVATIVES

1991
- 1991-07-15 RO RO148008A patent/RO113611B1/en unknown
- 1991-07-24 DE DE59102620T patent/DE59102620D1/en not_active Expired - Fee Related
- 1991-07-24 MC MC912206A patent/MC2274A1/en unknown
- 1991-07-24 EP EP91112368A patent/EP0469440B1/en not_active Expired - Lifetime
- 1991-07-24 DK DK91112368.5T patent/DK0469440T3/en active
- 1991-07-24 ES ES91112368T patent/ES2058999T3/en not_active Expired - Lifetime
- 1991-07-24 US US07/733,756 patent/US5158776A/en not_active Expired - Lifetime
- 1991-07-24 DE DE4124481A patent/DE4124481A1/en not_active Withdrawn
- 1991-07-24 AT AT91112368T patent/ATE110261T1/en not_active IP Right Cessation
- 1991-07-30 MX MX9100441A patent/MX9100441A/en unknown
- 1991-07-31 JP JP3191414A patent/JP3061898B2/en not_active Expired - Fee Related
- 1991-08-01 PT PT98532A patent/PT98532B/en not_active IP Right Cessation
- 1991-08-01 IL IL9903191A patent/IL99031A/en not_active IP Right Cessation
- 1991-08-01 NZ NZ239222A patent/NZ239222A/en not_active IP Right Cessation
- 1991-08-01 SI SI9111342A patent/SI9111342B/en not_active IP Right Cessation
- 1991-08-01 BG BG94934A patent/BG60900B1/en unknown
- 1991-08-01 EG EG46991A patent/EG19690A/en active
- 1991-08-02 HU HU912594A patent/HU206268B/en not_active IP Right Cessation
- 1991-08-02 CN CN91105271A patent/CN1046851C/en not_active Expired - Fee Related
- 1991-08-02 AU AU81589/91A patent/AU643309B2/en not_active Ceased
- 1991-08-02 CZ CS912409A patent/CZ280475B6/en not_active IP Right Cessation
- 1991-08-02 IE IE277491A patent/IE66378B1/en not_active IP Right Cessation
- 1991-08-02 ZA ZA916124A patent/ZA916124B/en unknown
- 1991-08-02 CA CA002048367A patent/CA2048367C/en not_active Expired - Lifetime
- 1991-08-02 AR AR91320329A patent/AR247484A1/en active
- 1991-08-02 NO NO913019A patent/NO178252C/en not_active IP Right Cessation
- 1991-08-02 SK SK2409-91A patent/SK279740B6/en not_active IP Right Cessation
- 1991-08-02 FI FI913710A patent/FI97951C/en active
- 1991-08-02 KR KR1019910013365A patent/KR0177170B1/en not_active Expired - Fee Related
1992
- 1992-09-29 HR HRP-1342/91A patent/HRP920575B1/en not_active IP Right Cessation
- 1992-10-27 LV LVP-92-172A patent/LV10043B/en unknown
1993
- 1993-08-23 AU AU44836/93A patent/AU649184B2/en not_active Ceased
- 1993-09-03 LT LTIP921A patent/LT3528B/en not_active IP Right Cessation
1994
- 1994-12-30 SG SG181694A patent/SG181694G/en unknown
1995
- 1995-02-06 HK HK15695A patent/HK15695A/en not_active IP Right Cessation
1998
- 1998-04-27 SK SK543-98A patent/SK279739B6/en not_active IP Right Cessation
2000
- 2000-01-14 JP JP2000006836A patent/JP3545300B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SK279739B6 (en)	1999-03-12
SK279740B6 (en)	1999-03-12
MX9100441A (en)	1992-04-01
NZ239222A (en)	1993-01-27
CA2048367C (en)	2000-05-23
EP0469440A1 (en)	1992-02-05
HK15695A (en)	1995-02-10
CS240991A3 (en)	1992-03-18
ZA916124B (en)	1992-04-29
NO913019L (en)	1992-02-04
JP3061898B2 (en)	2000-07-10
LTIP921A (en)	1995-03-27
CZ280475B6 (en)	1996-01-17
JP3545300B2 (en)	2004-07-21
SI9111342A (en)	1998-04-30
AU643309B2 (en)	1993-11-11
FI913710L (en)	1992-02-04
IE912774A1 (en)	1992-02-12
IE66378B1 (en)	1995-12-27
JP2000229860A (en)	2000-08-22
IL99031A (en)	1996-09-04
IL99031A0 (en)	1992-07-15
SI9111342B (en)	1998-10-31
KR0177170B1 (en)	1999-03-20
CN1058715A (en)	1992-02-19
KR920003963A (en)	1992-03-27
NO178252C (en)	1996-02-21
PT98532A (en)	1992-06-30
LV10043B (en)	1995-06-20
LT3528B (en)	1995-11-27
HU206268B (en)	1992-10-28
FI97951B (en)	1996-12-13
JPH04243828A (en)	1992-08-31
MC2274A1 (en)	1993-06-23
AU649184B2 (en)	1994-05-12
BG94934A (en)	1993-12-24
EP0469440B1 (en)	1994-08-24
HUT59316A (en)	1992-05-28
LV10043A (en)	1994-05-10
AR247484A1 (en)	1995-01-31
HRP920575B1 (en)	1999-04-30
ES2058999T3 (en)	1994-11-01
FI913710A0 (en)	1991-08-02
CA2048367A1 (en)	1992-02-04
HU912594D0 (en)	1992-01-28
SG181694G (en)	1995-05-12
RO113611B1 (en)	1998-09-30
DE4124481A1 (en)	1992-02-06
HRP920575A2 (en)	1995-04-30
PT98532B (en)	1999-01-29
ATE110261T1 (en)	1994-09-15
BG60900B1 (en)	1996-06-28
US5158776A (en)	1992-10-27
NO913019D0 (en)	1991-08-02
FI97951C (en)	1997-03-25
AU8158991A (en)	1992-02-06
CN1046851C (en)	1999-12-01
NO178252B (en)	1995-11-13
DE59102620D1 (en)	1994-09-29
AU4483693A (en)	1993-11-11
EG19690A (en)	1995-09-30

Publication	Publication Date	Title
ITRM920361A1 (en)	1993-11-12	PHARMACEUTICAL COMPOSITIONS CONTAINING AN ALLYLAMINIC COMPOUND AS THE ACTIVE INGREDIENT.
FI951901L (en)	1995-04-21	Stable extended-release, orally administered formulation
FI973452L (en)	1997-08-22	Recorded dosage form for extended release of the active ingredient
IT8921118A0 (en)	1989-07-07	COMPOSITION FOR AEROSOL INCLUDING NITROGLYCERIN AS THE ACTIVE INGREDIENT.
NO933239D0 (en)	1993-09-10	Bioerodible device for administering active ingredients
NO20041287L (en)	2004-03-26	Compressed solid oral dosage forms of valsartan
FI930657A7 (en)	1993-08-18	Method for preparing dosage forms with extended active ingredient release
DE68901492D1 (en)	1992-06-17	ORAL COMPOSITIONS.
AR240225A1 (en)	1990-03-30	INSECTICIDE COMPOSITION THAT INCLUDES MORE THAN ONE ACTIVE COMPOUND.
FI831952A7 (en)	1983-12-08	Storage-stable tablets containing hydrolysis-sensitive active ingredient.
FI925778A0 (en)	1992-12-18	PHARMACEUTICAL ACTIVE benzoquinazoline active ingredient
IT1190824B (en)	1988-02-24	PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
DK1140031T3 (en)	2003-12-01	Pharmaceutical composition for controlled release with tilidine mesylate as active substance
NO910874L (en)	1991-09-09	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIDE INGREDIENTS.
DK0469440T3 (en)	1994-11-14	Solid oral dosage forms containing as active ingredient ifosamide
FI910254L (en)	1991-07-19	ORAL ACTIVE RENINING INHIBITORER.
TR200001121T2 (en)	2000-09-21	Antirheumatic substance.
DK0668290T3 (en)	1999-07-26	Physiologically active substance capable of permeating the biomembrane
TR27833A (en)	1995-08-31	"Pour-on" formulation for the application of anthelmintics.
DE59008309D1 (en)	1995-03-02	Fungicidal active ingredient combinations.
DE69007956D1 (en)	1994-05-11	Dental active ingredient containing anti-shrinkage additive.
DE59002649D1 (en)	1993-10-14	Fungicidal active ingredient combinations.
FI931159A7 (en)	1993-09-18	Dosaerosoler, which contains the active ingredient flezelastin and related structures
EP0729950A4 (en)	2001-02-07	ANTI-HIV DRUG
JPS545046A (en)	1979-01-16	Cephalosporin preparation for oral administration